The concentration of melatonin was determined in serum samples obtained at 15-min intervals during a 4-h period from seven normal girls, 9.5-16.5 yr of age, and eight normal boys, 9.0-16.8 yr of age. All samples were obtained between 0800 and 1300 h. An episodic pattern of melatonin secretion was found in all subjects. There was no significant (P greater than 0.1) difference between girls and boys as to number of episodes [3.1 +/- 0.4 (+/- SD) vs. 3.4 +/- 0.5 per 4 h), absolute melatonin increase (49.0 +/- 6.7 vs. 50.4 +/- 4.1 pg/ml), or apparent melatonin half-life (20.3 +/- 0.8 vs. 20.8 +/- 1.0 min). The mean absolute increase during secretory episodes correlated (r = 0.843; P less than 0.005) with the mean melatonin concentration per 4 h, and a significant (P less than 0.05) inverse correlation (r = -0.508) was found between the mean percent increment of the melatonin secretory episode and the mean apparent melatonin half-life. A significant correlation between melatonin secretion and previously reported (22) episodic LH secretion was not found. In girls and boys, the mean melatonin concentration increased with advancing puberty. The increase in melatonin concentration was due to an increase in the amplitude of secretory episodes. These data are consistent with an influence of gonadal function on melatonin secretion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1210/jcem-60-4-751 | DOI Listing |
In Vitro Cell Dev Biol Anim
January 2025
Department of Critical Care Medicine, The Qujing NO.1 People's Hospital, Qujing, 655000, Yunnan, China.
Melatonin (MEL), functioning as a circulating hormone, is important for the regulation of ferroptosis in different health scenarios and acts as a crucial antioxidant in cardiovascular diseases. However, its specific function in ferroptosis related to myocardial ischemia-reperfusion injury (MIRI) remains to be fully elucidated. In our research, we utilized a rat model of MIRI induced by coronary artery ligation, along with a cell model subjected to hypoxia/reoxygenation (H/R).
View Article and Find Full Text PDFJ Addict Dis
January 2025
Departments of Anesthesiology and Perioperative Medicine and Pharmacology, Penn State College of Medicine, Hershey, PA, USA.
Opioid use disorder (OUD) is associated with a reduction in brain white matter, affecting critical areas involved in decision-making, impulse control, and reward processing. The FDA has approved several drugs and natural compounds that enhance myelination, targeting oligodendrocyte progenitor cells (OPCs), directly enhancing oligodendrocyte (OL) function, or acting as cofactors for myelin production. This retrospective case study aimed to assess whether current clinical evidence supports the use of myelin-enhancing agents to promote remission in OUD.
View Article and Find Full Text PDFCancer Cell Int
January 2025
School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
This narrative review explores the link between breast cancer and night shift work in nurses, focusing on genetic and epigenetic factors. Breast cancer disproportionately affects women globally, and night shift work is increasingly recognized as a potential risk factor. Nurses who work consecutive overnight shifts face elevated risks due to disruptions in their circadian rhythms.
View Article and Find Full Text PDFPediatr Res
January 2025
Institute for Women's Health, University College London, WC1E 6HX, 74 Huntley Street, London, WC1E 6HX, UK.
Front Pharmacol
January 2025
Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Türkiye.
Aim: The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods.
Methods: Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!